May, F;Guenther, M;Fastenmeier, K;Hartung, R.Improved high-frequency surgery for transurethral resection of the prostate: Report from a multicenter trial and identification of risk groups.J Urol.2003.169 Suppl..4.467-467

Paul, R;Pfeifer, A;Van Randenborgh, H;Kubler, H;Hartung, R.Renal cell cancer: Is there a true difference in prognosis of papillary and clear cell type carcinomas?.J Urol.2003.169 Suppl..4.262-262

Weller, D;May, F;Rowett, D;Esterman, A;Pinnock, C;Nicholson, S;Doust, J;Silagy, C.Promoting better use of the PSA test in general practice: randomized controlled trial of educational strategies based on outreach visits and mailout..Fam Pract.2003.20.6.655-61

Barba, M;Fastenmeier, K;Hartung, R.Electrocautery: principles and practice..J Endourol.2003.17.8.541-55

May, F;Treiber, U;Hartung, R;Schwaibold, H.Significance of random bladder biopsies in superficial bladder cancer..Eur Urol.2003.44.1.47-50

Treiber, U;Schwaibold, H;Berger, H;Hartung, R.[Pseudoaneurysm of a subsegmental renal artery after percutaneous nephrolitholapaxy].Urologe A.2003.42.4.547-52

Weirich, G;Nährig, J;Treiber, U;Hartmann, C;Hartung, R;Höfler, H;Fend, F.Immunohistochemical assessment of a testicular tumor in a 63-year-old patient: proposal for an integrated clinicopathologic approach..Appl Immunohistochem Mol Morphol.2003.11.1.96-100

Heit, A;Maurer, T;Hochrein, H;Bauer, S;Huster, KM;Busch, DH;Wagner, H.Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells..J Immunol.2003.170.6.2802-5

Gerhard, MC;Zantl, N;Weirich, G;Schliep, S;Seiffert, B;Häcker, G.Functional evaluation of the apoptosome in renal cell carcinoma..Br J Cancer.2003.89.11.2147-54

Hartwig, SE;Faustel, R;Weirich, G;Treiber, U;Wagenpfeil, S;Hartung, R.Over-expression of HER2/NEU correlates with tumor-specific survival of patients with urothelial carcinoma of the bladder.J Urol.2003.169 Suppl..4.136-136